NCT05136365View on ClinicalTrials.gov

A Study of Xiongdan Wan Treating Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 28, 2021

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

Xiongdan Wan

Xiongdan Wan is used as 450mg three times a day after meals with water for 8 weeks. The daily dose (e.g. 450mg/bag, 3 times/day) should be strictly controlled according to the experimental design. Patients should take medicine regularly every day under the guidance of doctors.

Trial Locations (1)

200030

Shanghai Mental Health Center, Shanghai

All Listed Sponsors
lead

Shanghai Mental Health Center

OTHER

NCT05136365 - A Study of Xiongdan Wan Treating Depression | Biotech Hunter | Biotech Hunter